Abstract:Background: The human gut microbiota (GM) has been recognized as a significant factor in the development of insomnia, primarily through inflammatory pathways, making it a promising target for therapeutic interventions. Considering the principles of primary prediction, targeted prevention, and personalized treatment medicine (PPPM), identifying specific gut microbiota associated with insomnia and exploring the underlying mechanisms comprehensively are crucial steps towards achieving primary prediction, targeted prevention, and personalized treatment of insomnia. Working hypothesis and methodology: We hypothesized that alterations in the composition of specific GM could induce insomnia through an inflammatory response, which postulates the existence of a GM-inflammation-insomnia pathway. Mendelian randomization (MR) analyses were employed to examine this pathway and explore the mediative effects of inflammation. We utilized genetic proxies representing GM, insomnia, and inflammatory indicators (including 41 circulating cytokines and C-reactive protein (CRP)), specifically identified from European ancestry. The primary method used to identify insomnia-related GM and examine the medicative effect of inflammation was the inverse variance weighted method, supplemented by the MR-Egger and weighted median methods. Our findings have the potential to identify individuals at risk of insomnia through screening for GM imbalances, leading to the development of targeted prevention and personalized treatment strategies for the condition. Results: Nine genera and three circulating cytokines were identified to be associated with insomnia; only the associations of Clostridium (innocuum group) and β-NGF on insomnia remained significant after the FDR test, OR = 1.08 (95% CI = 1.04-1.12, P = 1.45 × 10-4, q = 0.02) and OR = 1.06 (95% CI = 1.02-1.10, P = 1.06 × 10-3, q = 0.04), respectively. CRP was associated with an increased risk of insomnia, OR = 1.05 (95% CI = 1.01-1.10, P = 6.42 × 10-3). CRP mediated the association of Coprococcus 1, Holdemania, and Rikenellaceae (RC9gut group) with insomnia. No heterogeneity or pleiotropy were detected. Conclusions: Our study highlights the role of specific GM alterations in the development of insomnia and provides insights into the mediating effects of inflammation. Targeting these specific GM alterations presents a promising avenue for advancing the transition from reactive medicine to PPPM in managing insomnia, potentially leading to significant clinical benefits. Supplementary information: The online version contains supplementary material available at 10.1007/s13167-023-00345-1.

Investigation of Common Pathways and Putative Biomarker Candidates of Colorectal Cancer and Insomnia by Using Integrative In-Silico Approaches

Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning

Identification of key genes and immune infiltration modulated in insomnia by integrated bioinformatics analysis and mendelian randomization study

Exploring shared biomarkers and shared pathways in insomnia and atherosclerosis using integrated bioinformatics analysis

Insomnia score: predictive ability of insomnia, high-diagnostic and prognostic value for cancer.

Identification Of Potential Biomarkers For Risk Analysis Of Colorectal Cancer Using A Combined Bioinformatics Analysis

Study on the potential mechanism, therapeutic drugs and prescriptions of insomnia based on bioinformatics and molecular docking

The predictive, preventive, and personalized medicine of insomnia: gut microbiota and inflammation

Integrative Analysis of Genome-Wide Association Study and Brain Region Related Enhancer Maps Identifies Biological Pathways for Insomnia

Identification of hub genes, key miRNAs and potential molecular mechanisms of colorectal cancer

The needle in the haystack: Identifying and validating common genes of depression, insomnia, and inflammation

Investigation of causal effects of blood metabolites on insomnia and circadian rhythm sleep wake disorders

Identification of potential drug targets for insomnia by Mendelian randomization analysis based on plasma proteomics

Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis

Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer

Analysis of the correlation between immune cell characteristics and insomnia: a Mendelian randomization study

Integrative genomics analysis identifies five promising genes implicated in insomnia risk based on multiple omics datasets

Metabolic Characteristics of Gut Microbiota and Insomnia: Evidence from a Mendelian Randomization Analysis

Exploring the Link between Premature Ovarian Insufficiency, Insomnia and Circadian Pathways

Impact of insomnia on ovarian cancer risk and survival: a Mendelian randomization study

Identifying novel links between cardiovascular disease and insomnia by Drosophila modeling of genes from a pleiotropic GWAS locus